FIM | EQ-5D-5L index score | |
---|---|---|
Pearson’s r | Pearson’s r | |
EQ-5D-5L index score | 0.627** | |
QLQ-C30 functional domainsa | ||
Physical functioning | 0.610** | 0.723** |
Role functioning | 0.325** | 0.602** |
Cognitive functioning | 0.354** | 0.584** |
Emotional functioning | 0.213 | 0.651** |
Social functioning | 0.171 | 0.482** |
Global health status | 0.129 | 0.430** |
QLQ-C30 symptom domainsa | ||
Nausea and vomiting | − 0.098 | − 0.228* |
Fatigue | − 0.331** | − 0.669** |
Dyspnea | − 0.433** | − 0.496** |
Pain | − 0.281* | − 0.533** |
Insomnia | − 0.184 | − 0.400** |
Appetite loss | − 0.139 | − 0.412** |
Constipation | − 0.110 | − 0.274* |
Diarrhea | − 0.157 | − 0.249* |
Financial difficulties | − 0.077 | − 0.406** |
BN20 symptom domainsb | ||
Future uncertainty | − 0.174 | − 0.566** |
Visual disorder | − 0.142 | − 0.256* |
Motor dysfunction | − 0.095 | − 0.448** |
Communication deficit | − 0.145 | − 0.374** |
Headache | 0.115 | 0.003 |
Seizure | 0.073 | − 0.231* |
Drowsiness | − 0.180 | − 0.524** |
Hair loss | 0.124 | − 0.141 |
Itchy skin | 0.081 | − 0.030 |
Weakness of legs | 0.017 | − 0.273* |
Loss of bladder control | − 0.265* | − 0.377** |